@Atul_Gawande Your view? A balanced mix of 1, 2 and 3 I assume? Which is greater threat- too little or too much regulation of this space?
-
-
-
.
@jflier My view? Too ill-informed yet. I want innovation but not thalidomide. Apps are transforming care but producing pt errors too. -
@Atul_Gawande Of course agree w your goals.This space seems partic challenging as "regulatory mindset" deals w radically personalizing innov
End of conversation
New conversation -
-
-
@Atul_Gawande is there any system or classification for reports for app-related#ptsafety incidents? http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000751/ …@EnricoCoiera -
@drohanlon@Atul_Gawande Our classification will work with apps but consumer behaviour may need to be add to mix - which starting now.
End of conversation
New conversation -
-
-
@Atul_Gawande I side with: FDA should regulate and consider apps etc., med device if patient safety is an issue, even if you use it yourselfThanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
@Atul_Gawande EKG would be regulated under FDA draft guidance. AliveCor has one such product.Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
@Atul_Gawande This is totally reasonable.Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
.
@Atul_Gawande intrsting! We want to vet devices promoted by experts but give ppl freedom to take health into own hands. How 2 have both?Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
@Atul_Gawande As a physician, I look to the FDA as a guide to let me know something is safe and effective. I don't have time to vett apps. -
@srawlingskramer@atul_gawande understandable, but FDA not infallible. Sometimes the process is scarily political. Then what?
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.